“a favorable trend”

A significant improvement in health-related quality of life was found at three months in favor of the IG, accompanied by a favorable trend toward enhanced mood.

Despite these methodological limitations, the results suggest a favorable trend in clinical markers.

In addition, other factors such as pCR, MPR, AFP-positive or elevated serum AFP levels and pN stage also showed a favorable trend (Figure. 4 B-F).

This suggested a favorable trend for both wound healing and infection resolution.

When remnant cholesterol was modeled as a categorical variable, we also observed a U-shaped association, whereas we did not observe a significantly greater or lower risk in the other three quartiles than in the lowest quartile, despite a favorable trend toward a lower risk in the third quartile [Q3: HR (95%CI): 0.67 (0.42-1.07)].

The GOURMET-HF trial [ 142 ], including both HFrEF and HFpEF patients, demonstrated that the Dietary Approach to Stop Hypertension (DASH)/sodium-restricted (SDR) diet has a favorable trend in rehospitalization at 30 days.

Additionally, high TIL levels, a known favorable prognostic factor in TNBC associated with improved survival and a higher likelihood of pCR [ 33 ], also demonstrated a favorable trend for pCR in our cohort.

The analysis of gastric cancer-specific mortality, which included five trials of high methodological quality, showed a favorable trend but did not reach statistical significance (RR = 0.84; 95% CI: 0.62-1.12).

Results demonstrated that the pembrolizumab plus lenvatinib arm achieved significantly prolonged median PFS compared with sunitinib monotherapy (23.9 months versus 9.2 months; HR 0.39; 95% CI, 0.32–0.49; p < 0.001), markedly improved ORR (71.0% versus 36.1%), and showed a favorable trend in median OS (HR 0.66), although median OS was not reached in either arm.

This suggests a favorable trend of an improvement in glycemia. 4 Discussion The primary objectives of this trial, to confirm tolerability, safety, and feasibility, have been met.

Neflamapimod (target class: inflammation), a p38α kinase inhibitor, demonstrated a favorable trend for NRGN and decreased CSF levels of pTau181 and tTau in comparison to a placebo.

Moreover, the mannitol group exhibited a favorable trend (Table 3 ).

Although OS data remained immature, a favorable trend was observed.

Overall, these in vivo results indicate that micro/nano-scale surface modifications can partially mitigate the vascular inhibitory effects of ZOL, thereby contributing to a favorable trend toward improved early osseointegration.

Overall survival showed a favorable trend (hazard ratio =0.87; 95% CI: 0.69–1.09) though not yet statistically significant.

14 Awad and Voruganti 15 detected a favorable trend on a number of such outcomes, demonstrating that interest is increasing in including patients’ reports in the management of their psychiatric conditions, and indicated that electronic technology should be quickly adopted by the field to bring about patient self-reports through remote electronic means to enable evaluation in real time, enhance recruitment, and reduce cost.

A favorable trend toward improved PFS with D-VRd compared with VRd was also observed in CTC-high patients.

Analysis using the Tapio decoupling model revealed that most cities exhibited developmental decoupling characteristics during the study period, indicating that the human and built environment systems generally maintained a favorable trend of coordinated development.

45 , 46 Our study results showed that while outcomes of concurrent chemoradiotherapy were comparable to systemic treatment alone (ORR: 78% vs 69%, mPFS: 13.4 vs 9.2 months), the concurrent radiotherapy group demonstrated a favorable trend in hazard ratio (HR = 1.78, 95% CI: 0.70–4.54) suggesting better prognosis, though the difference did not reach statistical significance ( p = 0.23).

The pooled analysis for all-cause mortality showed a favorable trend (OR 0.63), however the confidence interval (0.33–1.20) crossed unity, indicating the data remains underpowered to confirm statistical significance for mortality as a stand-alone endpoint.

POPular Genetics similarly demonstrated a favorable trend in ischemic and bleeding outcomes with genotype‐guided therapy [ 27 ].

Also, there was a favorable trend for amitriptyline 75 mg (8 weeks: −2.87 days), but the quality of evidence was low, and the credible intervals were wide.

Moreover, the improvement in RL min is accompanied by a reduction in the matching thickness, which is a favorable trend for high‐temperature EMW absorbers.

Thus, the Perioperative chemotherapy versus surveillance in upper Tract urothelial cancer (POUT) trial revealed a significant improvement in DFS, MFS, and DSS with a favorable trend in OS for adjuvant chemotherapy in locally advanced UTUC.

In the present study, the average age of the patients was higher and the average visual acuity was better, indicating a favorable trend in pericentral RP compared to typical RP.